PTEN and glioblastoma: The most common genomic alterations of the mesenchymal subtype of GBM are deletions of neurofibromin 1 (NF1) and phosphatase and tensin homolog (PTEN), which lead to the continuous activation of the protein kinase B (PKB, also known as AKT) pathway.